APP and Alzheimer disease: In this study, we selected 7-month old APP/PS1 double transgenic mice as the AD animal model, and applied Morris water maze (MWM) and non-invasive in vivo imaging micro-positron emission tomography (micro-PET) to evaluate the effect of EA treatment.